Knowledge

David J. Blackbourn

Source 📝

25: 80:. His research interests emphasise virus understanding how viruses have evolved to manipulate immune responses. Having previously been Head of the School of Biosciences and Medicine for 8 years. He is also a co-founder of Ducentis BioTherapeutics to produce a novel anti-inflammatory therapeutic drug and until September 2022, was non-executive board member. Blackbourn is an Editor-in-Chief of 114:
as lecturer in virology. After 4 years, in 2003, he was promoted to Senior Lecturer in Virology, followed by Reader in Virology in 2005. Having left Glasgow for Birmingham, he became Reader in Tumour Virology. In 2010 he was made Professor of Virology and in 2013 Honorary Senior Research Fellow.
128:
In 2014, Ducentis BioTherapeutics was founded based on research Blackbourn had done early in his independent career. In September 2022, Ducentis BioTherapeutics was acquired by Arcutis Therapeutics in a deal worth up to US$ 400 million.
49: 248: 122:, as Head of the Department of Microbial and Cellular Sciences. He was quickly promoted to Head of the School of Biosciences and Medicine and spent 8 years in the role (2013–2021). 170: 125:
After his time at Surrey, in 2022 he moved to the University of Aberdeen as Professor of Virology and Director of the Institute of Medical Sciences.
293: 298: 188: 99: 39: 110:(KSHV). This position led to becoming a Staff Scientist in 1997. Upon returning to the UK in 1999, he joined the 107: 95: 98:
in 1990 working on immune responses to Simian Immunodeficiency Virus (SIV). In 1993, after Davis, he moved to
146: 288: 103: 249:"Arcutis buys UK's Ducentis for up to $ 400M, as charity Lifearc celebrates first exit from venture arm" 82: 76:
PhD FRSB is currently Professor of Virology and Director of the Institute of Medical Sciences at the
102:, again as a Post-doctoral Researcher, this time in the lab of Jay A. Levy, M.D. where he worked on 303: 77: 206: 111: 119: 171:"Meet the new Editors-in-Chief of FEMS Microbiology Reviews: David J. Blackbourn (1 of 3)" 54: 8: 269: 35: 224: 273: 282: 189:"Virology expert appointed Head of the School of Biosciences and Medicine" 147:"Celebrating students' achievement in biosciences | University of Surrey" 44: 207:"Professor David J. Blackbourn | The Institute of Medical Sciences" 94:
Under Ronald Chuang, PhD, he became a Post-doctoral Researcher at
24: 280: 225:"Ducentis BioTherapeutics: Board Members" 294:Academics of the University of Aberdeen 100:University of California, San Francisco 281: 299:Academics of the University of Surrey 18: 118:As Professor of Virology he joined 13: 14: 315: 263: 23: 96:University of California, Davis 241: 217: 199: 181: 163: 139: 1: 132: 108:Kaposi's Sarcoma Herpesvirus 104:Human Immunodeficiency Virus 7: 10: 320: 89: 83:FEMS Microbiology Reviews 272:publications indexed by 38:, as no other articles 211:University of Aberdeen 78:University of Aberdeen 112:University of Glasgow 74:David John Blackbourn 193:University of Surrey 151:University of Surrey 120:University of Surrey 289:British virologists 270:David J. Blackbourn 57:for suggestions. 47:to this page from 16:British virologist 71: 70: 311: 257: 256: 245: 239: 238: 236: 235: 221: 215: 214: 203: 197: 196: 185: 179: 178: 167: 161: 160: 158: 157: 143: 66: 63: 52: 50:related articles 27: 19: 319: 318: 314: 313: 312: 310: 309: 308: 279: 278: 266: 261: 260: 247: 246: 242: 233: 231: 223: 222: 218: 205: 204: 200: 187: 186: 182: 169: 168: 164: 155: 153: 145: 144: 140: 135: 92: 67: 61: 58: 48: 45:introduce links 28: 17: 12: 11: 5: 317: 307: 306: 301: 296: 291: 277: 276: 274:Google Scholar 265: 264:External links 262: 259: 258: 240: 216: 198: 180: 177:. 13 May 2019. 162: 137: 136: 134: 131: 91: 88: 69: 68: 55:Find link tool 31: 29: 22: 15: 9: 6: 4: 3: 2: 316: 305: 304:Living people 302: 300: 297: 295: 292: 290: 287: 286: 284: 275: 271: 268: 267: 254: 250: 244: 230: 226: 220: 212: 208: 202: 194: 190: 184: 176: 172: 166: 152: 148: 142: 138: 130: 126: 123: 121: 116: 113: 109: 105: 101: 97: 87: 85: 84: 79: 75: 65: 56: 51: 46: 42: 41: 37: 32:This article 30: 26: 21: 20: 252: 243: 232:. Retrieved 229:Ducentis Bio 228: 219: 210: 201: 192: 183: 174: 165: 154:. Retrieved 150: 141: 127: 124: 117: 93: 81: 73: 72: 62:January 2023 59: 33: 283:Categories 234:2022-05-13 156:2022-05-13 133:References 106:(HIV) and 53:; try the 40:link to it 43:. Please 253:BioWorld 90:Career 36:orphan 34:is an 175:FEMS 285:: 251:. 227:. 209:. 191:. 173:. 149:. 86:. 255:. 237:. 213:. 195:. 159:. 64:) 60:(

Index


orphan
link to it
introduce links
related articles
Find link tool
University of Aberdeen
FEMS Microbiology Reviews
University of California, Davis
University of California, San Francisco
Human Immunodeficiency Virus
Kaposi's Sarcoma Herpesvirus
University of Glasgow
University of Surrey
"Celebrating students' achievement in biosciences | University of Surrey"
"Meet the new Editors-in-Chief of FEMS Microbiology Reviews: David J. Blackbourn (1 of 3)"
"Virology expert appointed Head of the School of Biosciences and Medicine"
"Professor David J. Blackbourn | The Institute of Medical Sciences"
"Ducentis BioTherapeutics: Board Members"
"Arcutis buys UK's Ducentis for up to $ 400M, as charity Lifearc celebrates first exit from venture arm"
David J. Blackbourn
Google Scholar
Categories
British virologists
Academics of the University of Aberdeen
Academics of the University of Surrey
Living people

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.